Table 3.

Bivariable analysis of DVT characteristics and PTS CAPTSure scores by CVC status and affected extremity

VariableEstimate (95% CI)P
≥1 completely occlusive segments at diagnosis   
 Non–CVC- vs CVC-related thrombosis 3.4 (1.1-10.3)* .03 
 LE vs UE 3.2 (1.9-5.5)* <.001 
Edema in extremity   
 Non–CVC- vs CVC-related thrombosis 3.5 (1.5-8.2)* .004 
 LE vs UE 3.2 (2.0-5.2)* <.001 
Changes in skin color, temperature, or perfusion   
 Non–CVC- vs CVC-related thrombosis 0.3 (0.1-1.2)* .09 
 LE vs UE 4.1 (2.1-8.3)* <.001 
CVC dysfunction   
 LE vs UE 0.2 (0.1-0.9)* .03 
Pain in extremity   
 Non–CVC- vs CVC-related thrombosis 32.2 (13.1-79.2)* <.001 
 LE vs UE 1.4 (0.6-3.4)* .43 
CAPTSure score   
 Non–CVC- vs CVC-related thrombosis 9.2 (3.4-15.1)† .002 
 LE vs UE 1.8 (−0.9 to 4.4)† .19 
BMI percentile at time of PTS assessment   
 Non–CVC- vs CVC-related thrombosis 19.2 (8.9-29.5)† <.001 
 LE vs UE 1.4 (–0.5 to 3.2)† .14 
VariableEstimate (95% CI)P
≥1 completely occlusive segments at diagnosis   
 Non–CVC- vs CVC-related thrombosis 3.4 (1.1-10.3)* .03 
 LE vs UE 3.2 (1.9-5.5)* <.001 
Edema in extremity   
 Non–CVC- vs CVC-related thrombosis 3.5 (1.5-8.2)* .004 
 LE vs UE 3.2 (2.0-5.2)* <.001 
Changes in skin color, temperature, or perfusion   
 Non–CVC- vs CVC-related thrombosis 0.3 (0.1-1.2)* .09 
 LE vs UE 4.1 (2.1-8.3)* <.001 
CVC dysfunction   
 LE vs UE 0.2 (0.1-0.9)* .03 
Pain in extremity   
 Non–CVC- vs CVC-related thrombosis 32.2 (13.1-79.2)* <.001 
 LE vs UE 1.4 (0.6-3.4)* .43 
CAPTSure score   
 Non–CVC- vs CVC-related thrombosis 9.2 (3.4-15.1)† .002 
 LE vs UE 1.8 (−0.9 to 4.4)† .19 
BMI percentile at time of PTS assessment   
 Non–CVC- vs CVC-related thrombosis 19.2 (8.9-29.5)† <.001 
 LE vs UE 1.4 (–0.5 to 3.2)† .14 

OR, odds ratio. * Odds ratios; † coefficient estimates

Close Modal

or Create an Account

Close Modal
Close Modal